Search

A clinical trial, NCT06638502, is being conducted to evaluate the safety and tolerability of HRX215 in adults who have undergone surgical removal of metastatic tumors due to colorectal carcinoma in the liver. The study aims to assess the safety, absorption, distribution, and elimination of HRX215 compared to a placebo over a 28-day period. Participants will receive HRX215 or a placebo twice daily, with regular checkups and clinic visits for monitoring. The trial is set to conclude on July 1, 2025, with a primary focus on adverse events and pharmacokinetic plasma analysis. [Extracted from the article]

A study conducted at Seoul National University compared laparoscopic anatomical resection (LAR) and laparoscopic non-anatomical resection (LNAR) for hepatocellular carcinoma (HCC) in the posterosuperior (PS) segments of the liver. The research found that LNAR was associated with shorter operation time, lower blood loss, lower transfusion rate, and shorter hospital stay compared to LAR. While LNAR had a higher intrahepatic recurrence rate, post-recurrence treatments differed significantly between the two groups, with the re-resection rate being much greater in the LNAR group. The study concluded that LNAR is safe and feasible for HCC in the PS segments, providing comparable oncologic outcomes to LAR. [Extracted from the article]

A recent study conducted at the Mayo Clinic in Phoenix, Arizona, focused on the outcomes of laparoscopic ventral hernia repairs in liver transplant recipients. The study included 89 patients and found that the repairs were successful with low rates of recurrence and complications. The research concluded that despite the complexity of hernia defects in liver transplant recipients, laparoscopic ventral hernia repair can be a safe and effective treatment option. The study has been peer-reviewed and provides valuable insights into post-transplant hernia management. [Extracted from the article]

A study conducted at Sun Yat-sen University in Guangdong, China, compared the outcomes of partial hepatectomy and interventional treatment for patients with Hepatitis B Virus-related Hepatocellular Carcinoma and clinically significant portal hypertension. The research found that while partial hepatectomy did not significantly improve overall survival or recurrence-free survival compared to interventional treatment, it is still considered a safe procedure and a viable treatment option. The study highlights the importance of considering different treatment options for patients with HBV-related HCC within the Milan criteria and clinically significant PHT. [Extracted from the article]

The article discusses a clinical trial, NCT06632444, focusing on the use of survodutide to help individuals with non-alcoholic steatohepatitis (NASH) or metabolic-associated steatohepatitis (MASH) and moderate or advanced liver fibrosis improve their liver function. The study involves two parts, with participants randomly assigned to receive either survodutide or a placebo, injected weekly under the skin. The trial aims to assess the impact of survodutide on liver function and safety over a period of up to 7 years, with regular monitoring and assessments conducted throughout the study. [Extracted from the article]

A study conducted at the University Medical Center Groningen in the Netherlands focused on the outcomes of treatment strategies for hepatic artery stenosis (HAS) after pediatric liver transplantation (pLT). The research found that both endovascular therapy (EVT) and conservative management showed high graft survival rates for late HAS, with EVT achieving high technical success. The study included 327 pLT patients, with 4% developing HAS, and the long-term outcomes of HAS after pLT were reported to be excellent. [Extracted from the article]

Researchers at the University of Science and Technology China conducted a study on Enhanced Recovery After Liver Transplantation (ERAS) focusing on quality assessment. The study included 68 liver transplant recipients and found that the ERAS approach is feasible and offers opportunities for enhanced recovery and quality management. The research was funded by the Natural Science Foundation of Anhui Province and the Fundamental Research Funds for the Central Universities. The study was peer-reviewed and concluded that the ERAS protocol in liver transplantation shows promise for improving patient outcomes. [Extracted from the article]

Researchers from the University of Texas MD Anderson Cancer Center have developed a machine learning model to predict intraoperative hypotension during hepatobiliary surgery. The model incorporates demographic and physiological features to improve prediction performance and includes a 'dial' feature to adjust sensitivity and specificity. The study cohort consisted of adult patients undergoing surgery, with the multivariate model showing promising results in predicting hypotension events. This research has been peer-reviewed and offers a novel approach to forecasting intraoperative hypotension. [Extracted from the article]

The article discusses a newly launched clinical trial, NCT06626269, focusing on identifying innovative biomarkers related to the immune system or tumor microenvironment to enhance the effectiveness of immunotherapies. The research aims to understand how specific T cells and memory lymphocytes in patients' blood can impact long-term clinical protection and response to immunotherapy. By analyzing immune responses through tumor microenvironment and plasma molecules, researchers seek to predict treatment efficacy and address why some cancers are resistant to immunomodulatory drugs. The primary goal is to identify biomarkers that can help stratify and monitor patients undergoing immunotherapy, ultimately refining eligibility criteria for treatment strategies. [Extracted from the article]

A recent study conducted at the University Hospital of the RWTH Aachen in Germany has examined the relationship between splenic hypertrophy (SH) and liver-specific complications (LSC) in patients undergoing major liver resection for colorectal liver metastases (CRLM) after preoperative chemotherapy. The study found that patients with SH greater than 8.6% were more likely to experience LSC, and this was identified as an independent risk factor. The researchers suggest that preoperative SH may be a valuable predictor of postoperative LSC in these patients. Further research is needed to investigate the impact on a larger cohort and develop preventive strategies for chemotherapy-associated liver injury (CALI). [Extracted from the article]

A recent study conducted by researchers at Southern Medical University investigated the role of leukocyte cell-derived chemotaxin 2 (LECT2) in hepatic ischemia-reperfusion injury (IRI) and explored the therapeutic potential of Lect2-short hairpin RNA (shRNA) delivered through adeno-associated virus (AAV) vectors. The study found that elevated LECT2 levels during hepatic IRI increased liver damage, but genetic knockout or shRNA-mediated knockdown of Lect2 reduced liver damage, indicating its therapeutic potential. AAV-mediated Lect2-shRNA delivery mitigated hepatic IRI, suggesting a potential new treatment strategy for patients undergoing liver-related surgeries or trauma. [Extracted from the article]

A researcher at Okayama University Graduate School of Medicine in Japan has conducted a study on the predictive significance of the liver transection area (LTA) for laparoscopic liver surgery (LLS). The study included 106 patients who underwent LLS, and the researchers found that the LTA was significantly associated with surgical difficulty and operative time. The study concluded that the LTA is a useful parameter that reflects the difficulty of LLS. This research provides valuable insights for surgeons and medical professionals involved in liver resection procedures. [Extracted from the article]

A recent report from the Amrita Institute of Medical Science in Kerala, India discusses a case study of a 61-year-old male who underwent a living donor liver transplantation (LDLT) for chronic liver disease with hepatocellular carcinoma. During the procedure, a prosthetic polytetrafluoroethylene (PTFE) graft was used to reconstruct the middle hepatic vein. Follow-up examinations revealed that the PTFE graft had eroded into the duodenum, but due to the absence of symptoms and the risk associated with removing the graft, no intervention was performed. The patient continues to remain well after a 3-year follow-up period. The study suggests that enteric erosion of a prosthetic graft following LDLT can be managed conservatively, although the long-term consequences are unknown. [Extracted from the article]

A recent study conducted at the Clinical Research Center has provided new insights into liver transplants, specifically in pediatric patients. The study focused on the successful application of percutaneous endoscopic cholangioscopy and electrohydraulic lithotripsy for hepatolithiasis, a condition involving the presence of gallstones in the bile ducts, after liver transplantation. The case report highlighted the effectiveness of this method in accurately identifying and removing intrahepatic stones without the need for surgical intervention. The study is particularly relevant as there is currently limited literature on this approach in pediatric liver transplant cases. [Extracted from the article]

A recent study conducted at National Cheng Kung University in Tainan, Taiwan, has developed a mixed-reality training system for living donor liver transplantation (LT) surgery. The system utilizes a simulated liver phantom and iterative closest point (ICP) tracking technology to enhance the accuracy of middle hepatic vein (MHV) tracking during surgery. The researchers created a 3D liver reconstruction model based on CT images and produced elastic liver phantoms with soft vessels inside. The experimental results showed positive feedback from novice surgeons who practiced with the system, suggesting that it could improve surgeon training and potentially be applied to other medical procedures in the future. [Extracted from the article]

A clinical trial has been launched in China to investigate the correlation between lipid metabolites and the development of hepatocellular carcinoma, a common malignant tumor in the country. The study aims to provide new ideas for the early diagnosis and treatment of primary hepatocellular carcinoma and the screening of hepatocellular carcinoma markers. The trial will involve qualitative and quantitative analyses of lipid metabolites in plasma and liver cancer tissues of hepatic resection patients with hepatocellular carcinoma. The research is significant due to the increasing incidence of primary liver cancer caused by hepatic steatosis or metabolic dysfunction-related liver disease. [Extracted from the article]

A recent study conducted in China examined the outcomes of bariatric surgery in patients with unexpected liver cirrhosis. The study found that bariatric surgery can be safely performed in patients with compensated liver disease, with low postoperative complications and no mortality reported during the one-year follow-up period. The study included 47 patients, with the majority having Child-Pugh class A cirrhosis. The average weight loss one year after surgery was 29.73%, and the remission rates of comorbidities such as dyslipidemia, type 2 diabetes, hypertension, and obstructive sleep apnea syndrome were high. This research provides valuable insights into the safety and efficacy of bariatric surgery in patients with liver cirrhosis. [Extracted from the article]

A recent study conducted by the University of Virginia Health System has developed a "fast-track" risk score to predict the feasibility of early extubation after liver transplant surgery. The study analyzed data from adult patients who underwent non-fulminant deceased donor liver transplantation (DDLT) between January 2014 and July 2019. The researchers identified several factors that were associated with early extubation, including a MELD score of less than 29, transfusion of less than 4 units of packed red blood cells (pRBCs), and transfusion of less than 5 units of fresh frozen plasma (FFP) during surgery. The proposed risk score provides a quick and easy method to identify DDLT patients who are suitable for early extubation. [Extracted from the article]

A recent study conducted by researchers at the University of Kentucky focused on perioperative outcomes after hepatectomy for hepatocellular carcinoma (HCC) among patients with cirrhosis, fatty liver disease, and clinically normal livers. The study analyzed data from the American College of Surgeons National Surgical Quality Improvement Project (ACS-NSQIP) database and found that hepatic parenchymal disease/texture and function, presence of portal hypertension, and the extent of the liver resection are critical determinants of perioperative risk among HCC patients. The study concluded that despite superior outcomes with liver transplantation, cirrhotic patients with HCC may opt for other forms of definitive treatment. [Extracted from the article]

A recent study conducted at Baylor University College of Medicine examined the incidence and risk factors for chronic rejection (CR) in pediatric liver transplantation. The researchers found that CR, a progressive immunological injury that can lead to long-term liver allograft dysfunction and loss, was present in 5.3% of the pediatric liver transplant recipients in their cohort. Risk factors for CR included post-transplant lymphoproliferative disorder, infections, autoimmune liver diseases, Black race, and multiple episodes of acute cellular rejection. The study also found that patients with CR had a higher rate of graft failure and lower overall survival compared to the control group. The researchers suggest that identifying these risk factors may help develop specialized immunosuppression protocols and closer monitoring to reduce morbidity and mortality from CR in pediatric liver transplant recipients. [Extracted from the article]

A new report from Vardhman Mahavir Medical College and Safdarjung Hospital in New Delhi, India, discusses a case of accidental cannulation of an amoebic liver abscess during pericardiocentesis, a procedure to drain fluid from the pericardial cavity. The case involved a 41-year-old male who presented with fever and chest pain. During the emergency pericardiocentesis, a pigtail inadvertently punctured the liver abscess. The report emphasizes the importance of image-guided pericardiocentesis to minimize procedural complications and highlights the need to consider a ruptured amoebic liver abscess in certain cases. [Extracted from the article]

A study conducted at Cliniques Universitaires Saint-Luc in Brussels, Belgium, examined the concept of failure to rescue (FTR) in pediatric living donor liver transplantation (LDLT). The study retrospectively reviewed 500 pediatric LDLT cases performed at a single center between 1993 and 2022. The research found that the overall patient and graft survival rates were high, with 1-year and 5-year survival rates of 94.5% and 92.1% for patients, and 92.7% and 89.8% for grafts, respectively. The study suggests that this analytical method may provide valuable insights for improving the quality of care in pediatric LDLT. [Extracted from the article]

A recent research article from the National Children's Medical Center in Tashkent, Uzbekistan discusses the use of robotic surgery in liver transplantation. The article highlights the benefits of robotic surgery for both living liver donors and recipients. Robotic hepatectomy in living donors reduces postoperative pain and scarring, while robotic liver implantation in recipients improves surgical accuracy. The article concludes that robotic systems offer precise control and reduced risk for complex procedures. For more information, the article "Robotic surgery in living liver donors and liver recipients" can be accessed through the Laparoscopic, Endoscopic and Robotic Surgery journal. [Extracted from the article]

A recent study conducted in Portland, Oregon examined the outcomes of different treatment strategies for patients with synchronous colorectal liver metastases. The study compared the liver-first approach to the primary-first/simultaneous approach and found that patients who underwent liver-first resection had inferior recurrence-free survival. The liver-first approach was associated with shorter recurrence-free survival, particularly in terms of extrahepatic recurrence. The study suggests that further research is needed to determine the oncologic risk associated with leaving the primary tumor in place and recommends multidisciplinary treatment sequencing and enhanced postoperative surveillance for patients undergoing liver-first resection. [Extracted from the article]

A recent study conducted at McGill University Health Center in Montreal, Canada, examined the outcomes of liver metastasis in patients with colorectal cancer. The researchers identified two distinct histopathological growth patterns (HGPs) of colorectal cancer liver metastasis (CRCLM) that have significantly different rates of patient survival and response to treatment. The study found that patients with angiogenic HGPs had a 5-year survival rate of 47.1%, while patients with vessel co-opting HGPs had a 5-year survival rate of 13%. The researchers concluded that determining the HGPs of liver tumors is crucial for patient prognostication and treatment optimization. [Extracted from the article]

A study conducted at the Second Xiangya Hospital in Hunan, China, examined the use of robotic surgery for the treatment of early-stage hepatocellular carcinoma (HCC), a type of liver cancer. The researchers focused on the Glissonean approach, a technique used in open and laparoscopic liver surgery. They found that purely robotic segmentectomy 7 using the Glissonean approach was safe and feasible, with comparable or better outcomes than other hepatic resections. The study concluded that although technically challenging, robotic segmentectomy 7 could be performed safely and effectively using the Glissonean approach. [Extracted from the article]

A recent study conducted by the Department of HPB Surgery and Liver Transplantation examined the impact of renal replacement therapy (RRT) on the outcomes of living donor liver transplantation (LDLT) for acute liver failure (ALF). The study found that the use of RRT significantly lowered serum ammonia levels and increased the chances of posttransplant survival. Additionally, patients in the RRT group had a higher rate of extubation and regained consciousness after LDLT compared to the no-RRT group. The findings suggest that RRT may reduce posttransplant mortality due to brainstem herniation. [Extracted from the article]

A recent study conducted by researchers at the Second Military Medical University investigated preoperative prognostic factors for intrahepatic cholangiocarcinoma (ICC) patients and proposed a new scoring system that combines CA19-9 and neutrophil/lymphocyte ratio (NLR). The study analyzed 1728 patients who underwent curative liver resections for ICC. The results showed that NLR and CA19-9 were independent risk factors affecting postoperative recurrence and overall survival (OS) in ICC patients. Based on these findings, a preoperative prognostic score was derived, dividing patients into low-risk, intermediate-risk, and high-risk groups. The study concluded that the scoring system effectively predicts the long-term prognosis of ICC patients undergoing curative liver resection. [Extracted from the article]

A study conducted by researchers at Taipei Medical University in Taiwan aimed to evaluate the impact of different pre-transplant local treatments on the survival of liver transplantation recipients with BCLC Stage A Hepatocellular Carcinoma (HCC). The study analyzed data from the Taiwan Cancer Registry and National Health Insurance Research Databases from 2012 to 2018. The findings showed that undergoing hepatectomy prior to liver transplantation was associated with superior survival outcomes compared to solely local treatments. The researchers concluded that hepatectomy should be considered as a vital component of the treatment strategy for patients with BCLC Stage A HCC. [Extracted from the article]

A recent study conducted at the University of Iowa Hospitals and Clinic explored the association between low preoperative phosphate levels and outcomes in liver resections. The study found that while the incidence of posthepatectomy liver failure was higher in patients with low preoperative phosphate levels, after propensity score matching, rates of posthepatectomy liver failure were similar between low and normal preoperative phosphate groups. The researchers concluded that further studies are needed to investigate this association and its relevance as a clinical prognostic factor for postoperative liver failure. This research has been peer-reviewed and published in the Journal of Surgical Research. [Extracted from the article]

A patent has been issued to Miromatrix Medical Inc. for the use of resected liver serum to enhance the engraftment, proliferation, and functionality of cells in liver engineering. The patent describes methods of using blood or serum obtained from mammals that have undergone liver surgery, such as a partial hepatectomy, to increase the seeding efficiency of cells onto decellularized liver or collagen grafts. The invention aims to address the limited availability of hepatocytes for medical therapy by improving their proliferation and functionality in vitro. The patent provides detailed methods and compositions for achieving these goals. [Extracted from the article]

A recent report from Aminu Kano Teaching Hospital in Nigeria discusses the impact of liver resection on survival in breast cancer patients with hepatic metastasis. The researchers conducted a systematic review and meta-analysis of relevant studies comparing metastasectomy to systemic therapy. The analysis found that patients who underwent surgery had superior overall survival rates compared to those who received systemic therapy alone, at one year, three years, and five years after metastasectomy. The researchers concluded that hepatic metastasectomy, in combination with systemic therapy, is more effective than systemic therapy alone for breast cancer patients with oligo-metastasis of the liver. [Extracted from the article]

A new report from Seoul, South Korea provides updated information on the safety and effectiveness of laparoscopic liver resection (LLR) for huge hepatocellular carcinomas (HCC) compared to open liver resection (OLR). The study found that there were no statistically significant differences in postoperative outcomes or oncologic survivals between LLR and OLR. However, the researchers note that further studies with larger sample sizes are needed to confirm these results. This research was conducted at Seoul National University Hospital and has been peer-reviewed. [Extracted from the article]

A recent study conducted at Emory University in Atlanta, Georgia has provided new information about liver cancer treatment. The study focused on hepatic resection as the primary treatment method for hepatocellular carcinoma (HCC) after orthotopic liver transplantation (OLT). The study found that hepatic resection following OLT is safe and associated with acceptable recurrence-free survival (RFS) and overall survival (OS) rates. The researchers concluded that hepatic resection should be considered as a treatment option for well-selected patients with HCC after OLT. [Extracted from the article]

Researchers from Sun Yat-sen University have conducted a study on hepatic ischemia-reperfusion (I/R) injury, a complication that can occur during liver surgery. The study focused on the cGAS-STING pathway, which is involved in the activation of the innate immune response. The researchers found that inhibiting the release of mitochondrial DNA (mtDNA) can protect against hepatic I/R injury by preventing the activation of the cGAS-STING pathway. This research provides valuable insights into potential strategies for mitigating the damage caused by hepatic I/R injury. [Extracted from the article]

A new report from the University of Montreal Hospital Center in Quebec, Canada, discusses the evolving trends in liver transplantation eligibility for older adults. Traditionally, liver transplantation has been limited to individuals under the age of 65, but the center has shifted away from using age as an absolute refusal criterion since 2019. The study found that after this shift, there was an increase in older patients being referred for liver transplantation and an increase in the proportion of older patients receiving transplants. The researchers emphasize the importance of actively promoting awareness of evolving eligibility criteria and improving transplantation accessibility for older patients. [Extracted from the article]

A recent study conducted at Keio University School of Medicine in Tokyo, Japan, has reported on a novel surgical approach for the treatment of hepatocellular carcinoma (HCC) in the caudate lobe of the liver. The caudate lobe presents surgical challenges due to the lack of distinct anatomical landmarks. The researchers developed a method that combines Takasaki's classification and indocyanine green negative counterstaining to enable precise anatomical caudate lobectomy. The procedure, which involves a glissonian approach and indocyanine green administration, resulted in complete tumor resection with minimal blood loss. The researchers believe that this innovative approach offers a promising solution for the treatment of caudate lobe HCC, potentially improving surgical outcomes and long-term prognosis. [Extracted from the article]

A recent study conducted by researchers at National Taiwan University Hospital examined the outcomes and survival rates of patients who underwent lung metastasectomy for primary liver tumors with pulmonary metastasis. The study included 147 patients who had undergone surgical resection, radiofrequency ablation, or transcatheter arterial embolization. The 5-year overall survival rate was found to be 22%, and several factors were associated with better survival rates, including surgical resection as the initial primary liver tumor treatment and lower Model for End-Stage Liver Disease (MELD)-Na scores. The findings of this study can help thoracic surgeons in selecting appropriate patients for surgery and predicting surgical outcomes. [Extracted from the article]

A recent report from Houston Methodist Hospital discusses the use of liver transplantation (LT) as a treatment for patients with unresectable liver tumors. The report highlights the importance of neoadjuvant interventions prior to surgery, which have shown positive outcomes. The study also explores the efficacy of immune checkpoint inhibitors (ICPIs) and locoregional treatments (LRTs) in combination with LT to increase eligibility for curative treatment. Additionally, the report discusses the use of liquid biopsy as a technique for early detection of cancer recurrence. The field of transplant oncology is rapidly advancing, and this report provides valuable insights into the evolving modalities of care. [Extracted from the article]

The Li Ka Shing Foundation has made a generous donation to the University of Hong Kong's Faculty of Medicine, allowing them to introduce the Histotripsy system for clinical trials. This groundbreaking technology uses high-intensity ultrasound waves to disrupt cancer tissue without harming healthy tissue, offering a non-invasive and effective treatment option for liver cancer patients. The donation also supports specialized training for doctors and radiologists to ensure optimal utilization of the technology. The introduction of histotripsy in Hong Kong affirms the city's leading position in adopting cutting-edge medical technology. [Extracted from the article]

The article explores a new nomogram model for predicting early recurrence of hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC) following radical resection. Topics discussed include the identification of risk factors for early recurrence, the use of Kaplan-Meier curves and multivariate Cox proportional hazards regression to analyze patient data, and the development and validation of a predictive model based on tumor diameter, microvascular invasion, and albumin levels.

A recent study conducted by Srinakharinwirot University in Thailand compared the outcomes of laparoscopic liver resection (LLR) versus open liver resection (OLR) for the treatment of liver tumors. The study found that for surgeons with limited experience, LLR is a safe option with fewer complications compared to OLR. The margin-free status, which indicates the completeness of tumor removal, was comparable between both groups. This research provides valuable insights for hepato-pancreato-biliary surgeons who are considering different surgical approaches for liver lesions. [Extracted from the article]

A recent study conducted at the City of Hope National Medical Center in Duarte, California, examined the use of liver resection as a treatment option for patients with neuroendocrine tumors that have spread to other parts of the body (extrahepatic disease). The study found that liver-direct therapies, including liver resection, were associated with improved survival outcomes for these patients. The researchers concluded that the decision to use liver resection should be made on a case-by-case basis, taking into account the individual patient's circumstances. This study provides new insights into the treatment of neuroendocrine tumors with extrahepatic disease. [Extracted from the article]

A recent study conducted by researchers at Washington University in St. Louis, Missouri, has reported on the first-ever robotic liver transplant (RLT) in North America and the first RLT using a whole graft from a deceased donor in the world. The study describes the surgical technique and preparation leading up to the operation, which was performed on a 62-year-old man with hepatitis C cirrhosis and hepatocellular carcinoma. The patient had a successful recovery without complications, demonstrating the feasibility of RLT in selected patients with chronic liver disease. Further research and experience are needed to fully understand the potential role of RLT in transplant surgery. [Extracted from the article]

Researchers from Huazhong University of Science and Technology in Wuhan, China, have conducted a retrospective study to investigate the significance of the psoas muscle index (PMI) in evaluating the post-transplant prognosis of liver cancer patients. The study found that patients with a higher PMI had significantly improved overall survival and disease-free survival rates compared to those with a lower PMI. The researchers developed a nomogram incorporating PMI, MELD score, and Hangzhou criteria, which demonstrated outstanding predictive performance for tumor recurrence after liver transplantation. This research suggests that PMI can serve as a valuable prognostic factor for liver cancer patients undergoing liver transplantation. [Extracted from the article]

Researchers at Sharif University of Technology in Tehran, Iran, have conducted a study on the interaction of waterjet with the liver during hepatectomy, or liver resection surgery. The study aimed to investigate the mechanical engineering aspects of waterjet surgery and validate the results through experimental and simulation methods. The findings suggest that increasing waterjet velocity can change the behavior of the liver from brittle to ductile, and the study provides insights that can help surgeons determine the best working range of waterjet devices for efficient operations. The research article is available in the journal Heliyon. [Extracted from the article]

A study conducted at Ohio State University compared laparoscopic and open liver resection surgeries for the treatment of colorectal cancer liver metastases (CRLM). The study used a novel methodological approach called the win ratio to assess the overall benefit of each procedure. The results showed that laparoscopic hepatectomy had a higher win ratio compared to open hepatectomy, indicating that laparoscopic surgery may be a preferred approach for CRLM patients. The study emphasized the positive outcomes of laparoscopic surgery, particularly in terms of short-term outcomes such as 90-day mortality and postoperative complications. [Extracted from the article]

This document provides information about a clinical trial, NCT06569524, that is currently underway in China. The trial aims to evaluate the effectiveness and safety of TQA2225/AP025 in treating Nonalcoholic Steatohepatitis (NASH), a liver disease. It is a Phase II study that is randomized, double-blind, and placebo-controlled. The primary goals of the trial are to assess the impact of TQA2225 on liver biopsy and the resolution of NASH. The trial is expected to be completed by December 31, 2026, and is sponsored by Chia Tai Tianqing Pharmaceutical Group Co., Ltd. [Extracted from the article]

A recent report from the Seoul National University College of Medicine in South Korea examines the outcomes of living donor liver transplantation (LDLT) for pediatric acute liver failure (PALF). The study found that while the survival rates for patients with PALF have improved in the contemporary transplant era, they still remain lower than those with chronic liver disease. The research suggests that early detection and proper management of rejection, along with caution regarding sepsis, could further improve outcomes for patients with PALF. The study was supported by the Ministry of Health, Labour and Welfare. [Extracted from the article]

A study conducted at Qingdao Women and Children's Hospital in China compared the use of three-dimensional (3D) and two-dimensional (2D) imaging in preoperative planning for pediatric middle hepatic tumors. The study analyzed 23 children who underwent surgery for these tumors and found that the use of 3D imaging with a computer-assisted surgery system was superior to 2D imaging. The 3D imaging allowed for more accurate surgical resection plans and resulted in successful tumor removal in all cases. The study suggests that 3D imaging should be considered for preoperative planning in pediatric hepatoblastoma cases. [Extracted from the article]